Altogether, these data suggested that PSG prevented the intestinal tract from leakage of IBD mice induced by DSS, and suppressed the IBD-associated secondary liver injury via inhibiting the LPS/TLR4/MyD88/NF-κB signaling pathway. This evidence concerns the gene NFKB1 and inflammatory bowel disease.